CNY 26.15
(1.67%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 1.94 Billion CNY | -9.52% |
2022 | 2.15 Billion CNY | 148.26% |
2021 | 868.16 Million CNY | 2733.83% |
2020 | 30.63 Million CNY | -14.9% |
2019 | 36 Million CNY | -13.04% |
2018 | 41.4 Million CNY | -11.54% |
2017 | 46.8 Million CNY | 0.0% |
2016 | - CNY | -100.0% |
2015 | 657 Thousand CNY | -66.67% |
2014 | 1.97 Million CNY | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 1.23 Billion CNY | 19.99% |
2024 Q1 | 1.02 Billion CNY | 0.84% |
2024 Q3 | 1.19 Billion CNY | -3.49% |
2023 Q3 | 1.87 Billion CNY | -6.0% |
2023 FY | 1.94 Billion CNY | -9.52% |
2023 Q2 | 1.99 Billion CNY | -2.24% |
2023 Q4 | 1.94 Billion CNY | 4.14% |
2023 Q1 | 2.03 Billion CNY | -5.46% |
2022 FY | 2.15 Billion CNY | 148.26% |
2022 Q4 | 2.15 Billion CNY | 0.1% |
2022 Q3 | 2.15 Billion CNY | 70.26% |
2022 Q2 | 1.26 Billion CNY | 5.85% |
2022 Q1 | 1.19 Billion CNY | 37.62% |
2021 Q2 | 722.2 Million CNY | 14.0% |
2021 FY | 868.16 Million CNY | 2733.83% |
2021 Q3 | 735.88 Million CNY | 1.89% |
2021 Q4 | 868.16 Million CNY | 17.98% |
2021 Q1 | 633.51 Million CNY | 1967.91% |
2020 Q4 | 30.63 Million CNY | -4.11% |
2020 FY | 30.63 Million CNY | -14.9% |
2020 Q3 | 31.95 Million CNY | -4.05% |
2020 Q2 | 33.3 Million CNY | 0.0% |
2020 Q1 | - CNY | -100.0% |
2019 Q4 | 36 Million CNY | 0.0% |
2019 FY | 36 Million CNY | -13.04% |
2018 FY | 41.4 Million CNY | -11.54% |
2017 Q1 | - CNY | 0.0% |
2017 Q4 | 46.8 Million CNY | 0.0% |
2017 Q2 | - CNY | 0.0% |
2017 FY | 46.8 Million CNY | 0.0% |
2016 FY | - CNY | -100.0% |
2015 FY | 657 Thousand CNY | -66.67% |
2014 FY | 1.97 Million CNY | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Shanghai No.1 Pharmacy Co., Ltd. | 107.24 Million CNY | -1718.281% |
Jointown Pharmaceutical Group Co., Ltd | 2.31 Billion CNY | 15.655% |
LBX Pharmacy Chain Joint Stock Company | 1.37 Billion CNY | -41.472% |
Yifeng Pharmacy Chain Co., Ltd. | 133.61 Million CNY | -1359.39% |